declan
Recently Joined
🚫No Source Discussion🚫
I was looking into the current phase 3 study for Eli Lilly's Eloralintide and I found that the trial is actually currently open and looking for volunteers. I thought I'd pass it along.
This is actually a "plateau busting" study, they're looking for people on tirz or sema who stalled. I think that may describe many of us who hit a wall and are exploring an amylin receptor agonist to break the plateau.
Elly Lilly will provide you free Eloralintide (or a placebo) to see whether it helps you break through your plateau. It's not clear to me whether they provide tirz or a stipend for it. Maybe someone else can clarify.
Some information/requirements:
You can apply by calling a study center near you to see if you qualify.
https://clinicaltrials.gov/study/NCT07392190
Good luck and thank you if you apply and help move the science forward.
This is actually a "plateau busting" study, they're looking for people on tirz or sema who stalled. I think that may describe many of us who hit a wall and are exploring an amylin receptor agonist to break the plateau.
Elly Lilly will provide you free Eloralintide (or a placebo) to see whether it helps you break through your plateau. It's not clear to me whether they provide tirz or a stipend for it. Maybe someone else can clarify.
Some information/requirements:
- Study ID: NCT07392190
- Duration: 80 weeks (approximately 1.5 years)
- Commitment: 22 clinic visits
- BMI: > 30 OR > 27 with at least one health issue (e.g., hypertension, sleep apnea).
- Medication Stability: On a stable, prescribed dose of a weekly GLP-1/GIP (Tirzepatide or Semaglutide) for the last 90 days.
- Weight Stability: Your weight must have remained within a 5% range (stalled) for the last 90 days.
- Documented History: Must have at least one self-reported unsuccessful attempt to lose weight through diet/exercise.
- Dose changes: if you increased or decreased your glp-1 in the last 90 days wait until you have 3 months of stability.
- Active weight loss: if you gained or lost more than 5% of your total body weight you won't qualify. They're looking for people who are truly stalled.
- Gray market peptide use: the trial protocol requires you to be on a "stable background incretin therapy" (their words).
- To a clinical researcher, "Stable" means they can see an official medical record or pharmacy receipt showing you received exactly 10mg or 15mg of FDA-approved Tirzepatide (Zepbound/Mounjaro) for the last 90 days.
- No major surgeries or adverse health events in the last 90 days.
You can apply by calling a study center near you to see if you qualify.
https://clinicaltrials.gov/study/NCT07392190
Good luck and thank you if you apply and help move the science forward.